Studying the Genetic Basis of Neurodevelopmental Channelopathies

The Scientist is bringing together a panel of experts to share their research, discuss current therapeutic approaches, and to offer their insights.

By The Scientist Creative Services Team | January 1, 2018

 

FREE Webinar

Wednesday, March 7, 2018
2:30-4:00 PM Eastern Time
Register Now

Neurodevelopmental channelopathies impact the responsiveness of cells in the central nervous system to typical electrochemical signals. These signal disruptions can range in severity, from mild to intense, leading to epilepsy and speech disturbances. In one example, genetic variations to a gene encoding a voltage-gated sodium channel (SCN3A) can result in neurodevelopmental delays and disturbances. Advanced Cell Diagnostics brings an expert whose research into the genetics of SCN3A-based channelopathies promises to untangle the web of SCN3A’s role in neurodevelopment and beyond. Attendees will have the opportunity to interact with experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • The molecular and mechanistic similarities and differences between neurodegenerative diseases
  • Whether primary and secondary neurodegeneration distinctions are based on biology

Register Now

Meet the Speakers:

Richard Smith, PhD
Postdoctoral Fellow, Christopher Walsh Laboratory
Harvard Medical School

 

 

Annelies Laeremans, PhD
Research Scientist R&D
Advanced Cell Diagnostics

 

 

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Stem Cell Vaccine Protects Mice From Cancer
  2. Love in the Scientific Literature
    News Analysis Love in the Scientific Literature

    There are countless ways for scientists to say, “I love you.” Naming a slime-mold beetle after your wife (and another after your ex-wife) is, apparently, one of them.  

  3. DNA Robots Target Cancer
    Daily News DNA Robots Target Cancer

    Researchers use DNA origami to generate tiny mechanical devices that deliver a drug that cuts off the blood supply to tumors in mice.

  4. CDC: Flu Vaccine 36 Percent Effective So Far
AAAS